Facebook
Twitter
LinkedIn
ForwardMayo Clinic Proceedings - Mechanisms of Disease: Inflammatory Bowel Diseases (January 2019)
One of the premier peer-reviewed clinical journals in general and internal medicine, Mayo Clinic Proceedings is among the most widely read and highly cited scientific publications for physicians, with a circulation of approximately 125,000. Mayo Clinic Proceedings is published by Elsevier and sponsored by Mayo Clinic and the Mayo Foundation for Medical Education and Research. The mission of Mayo Clinic Proceedings is to promote the best interest of patients by advancing the knowledge and professionalism of the physician community. Since 2009 the Journal has offered CME credit for specific articles from both the Mayo Clinic for Concise Review for Clinicians and specially commissioned Symposia articles (comprehensive coverage on one topic).
Participation in this activity consists of reviewing articles and responding to a short online test. It is estimated that this activity will take approximately one hour per article. There is no charge for participating in this Journal CME activity.
To receive CME credit, please do the following:
- Click Take Course
- Complete quiz and evaluation (There is a required 80% pass rate in order to earn credit, with 1 retake allowed.)
- Print your Record of Attendance
Questions? cme@mayo.edu
Target Audience
The target audience for Proceedings is primarily internal medicine physicians and other clinicians who wish to advance their current knowledge of clinical medicine and who wish to stay abreast of advances in medical research. There might be an occasional NP or PA as well.
Learning Objectives
On completion of this article, you should be able to:
- (1) define key elements of the intestinal barrier responsible for maintaining intestinal homeostasis
- (2) describe the major mechanisms involved in the pathogenesis of inflammatory bowel diseases (IBD)
- (3) recognize the importance of genetic factors in the contribution of IBD development
- (4) identify environmental factors, such as diet and medications, and their association with microbial dysbiosis and mucosal inflammation
- (5) describe different inflammatory pathways involved in patients with IBD and how they can be targeted therapeutically
DISCLOSURE SUMMARY:
As a Jointly Accredited Provider by ACCME, ACPE, and ANCC, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.
Listed below are individuals with control of the content of this program who have disclosed…
Planning Committee, Editorial Board Members and Staff
Christopher M. Wittich, M.D.
Authors Disclosure Summary
Authors: Guilherme Piovezani Ramos, MD, and Konstantinos A. Papadakis, MD
Affiliations: From the Department of Internal Medicine (G.P.R.) and Division of Gastroenterology and Hepatology (K.A.P., G.P.R.), Mayo Clinic, Rochester, MN.
Conflicts of Interest: Dr Papadakis is a stock shareholder in Pfizer Inc, GlaxoSmithKline plc, and Inc. Dr Ramos reports no competing interests.
Off-label drugs: None.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.
Accreditation Statement:
Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM
Successful completion of this CME activity enables the participant to earn up to 1 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
Participation information will be shared with ABIM through PARS.
Other Healthcare Professionals
A certificate of attendance will be provided to other healthcare professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.
Available Credit
- 1.00 ABIM
- 1.00 AMA PRA Category 1 Credit™
Cancellation and Refund Policy:
Request for cancellations must be submitted in writing to cme@mayo.edu. When cancelling a registration for a course 14 days or more before the course start date, a full refund (minus a $75 administrative fee) will be issued in the same form of payment the registration was received. No refunds are granted less than 14 days before the course start date.
Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.